Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin

Journal of General Virology

Volumn 95, Issue PART 5, 2014, Pages 1033-1042

  García Barreno, Blanca ^a,b   Delgado, Teresa ^a,b   Benito, Sonia ^a,b   Casas, Inmaculada ^a,c   Pozo, Francisco ^a,c   Cuevas, María Teresa ^a,c   Mas, Vicente ^a,b   Trento, Alfonsina ^a,b   Rodriguez Frandsen, Ariel ^b,d   Falcón, Ana ^b,d   Ortín, Juan ^b,d   Nieto, Amelia ^b,d   Melero, José A ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; VIRUS ANTIGEN;

2009 H1N1 INFLUENZA; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; POINT MUTATION; PRIORITY JOURNAL; VIRUS ATTACHMENT; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION, MISSENSE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 84899692145     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.061598-0     Document Type: Article

References (35)

1. Bautista, E., Chotpitayasunondh, T., Gao, Z., Harper, S. A., Shaw, M., Uyeki, T. M., Zaki, S. R., Hayden, F. G., Hui, D. S. & other authors (2010). Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362, 1708-1719.
2. Bembridge, G. P., Garcia-Beato, R., López, J. A., Melero, J. A. & Taylor, G. (1998). Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J Immunol 161, 2473-2480.
3. Blasco, R. & Moss, B. (1995). Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158, 157-162.
4. Brownlee, G. G. & Fodor, E. (2001). The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 356, 1871-1876.
5. Caton, A. J., Brownlee, G. G., Yewdell, J. W. & Gerhard, W. (1982). The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417-427.
6. Couch, R. B. & Kasel, J. A. (1983). Immunity to influenza in man. Annu Rev Microbiol 37, 529-549.
7. Gamblin, S. J. & Skehel, J. J. (2010). Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285, 28403-28409.
8. García-Barreno, B., Palomo, C., Peñas, C., Delgado, T., Perez-Breña, P. & Melero, J. A. (1989). Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol 63, 925-932.
9. Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E. & other authors (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197-201.
10. Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R. & other authors (2009). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361, 1945-1952.
11. Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura, D., Sakai-Tagawa, Y. & other authors (2009). In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021-1025.
12. Knossow, M. & Skehel, J. J. (2006). Variation and infectivity neutralization in influenza. Immunology 119, 1-7.
13. Koel, B. F., Burke, D. F., Bestebroer, T. M., van der Vliet, S., Zondag, G. C., Vervaet, G., Skepner, E., Lewis, N. S., Spronken, M. I. & other authors (2013). Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976-979.
14. Koopmans, M., Wilbrink, B., Conyn, M., Natrop, G., van der Nat, H., Vennema, H., Meijer, A., van Steenbergen, J., Fouchier, R. & other authors (2004). Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363, 587-593.
15. Krause, J. C., Tumpey, T. M., Huffman, C. J., McGraw, P. A., Pearce, M. B., Tsibane, T., Hai, R., Basler, C. F. & Crowe, J. E., Jr (2010). Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol 84, 3127-3130.
16. Magro, M., Mas, V., Chappell, K., Vázquez, M., Cano, O., Luque, D., Terrón, M. C., Melero, J. A. & Palomo, C. (2012). Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention. Proc Natl Acad Sci U S A 109, 3089-3094.
17. Manicassamy, B., Medina, R. A., Hai, R., Tsibane, T., Stertz, S., Nistal-Villán, E., Palese, P., Basler, C. F. & García-Sastre, A. (2010). Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6, e1000745.
18. Masoodi, T. A., Shaik, N. A., Shafi, G., Munshi, A., Ahamed, A. K. & Masoodi, Z. A. (2012). Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic. Gene 491, 200-204.
19. O'Donnell, C. D., Vogel, L., Wright, A., Das, S. R., Wrammert, J., Li, G. M., McCausland, M., Zheng, N. Y., Yewdell, J. W. & other authors (2012). Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. MBio 3.
20. Rodriguez, A., Falcon, A., Cuevas, M. T., Pozo, F., Guerra, S., García-Barreno, B., Martinez-Orellana, P., Pérez-Breña, P., Montoya, M. & other authors (2013). Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. PLoS ONE 8, e53515.
21. Sánchez-Fauquier, A., Villanueva, N. & Melero, J. A. (1987). Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch Virol 97, 251-265.
22. Shih, A. C., Hsiao, T. C., Ho, M. S. & Li, W. H. (2007). Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104, 6283-6288.
23. Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. & Fouchier, R. A. (2004). Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376.
24. Smith, G. J., Vijaykrishna, D., Bahl, J., Lycett, S. J., Worobey, M., Pybus, O. G., Ma, S. K., Cheung, C. L., Raghwani, J. & other authors (2009). Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459, 1122-1125.
25. Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A., Chen, L. M., Recuenco, S., Ellison, J. A., Davis, C. T. & other authors (2012). A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109, 4269-4274.
26. Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S. & other authors (2013). New World bats harbor diverse influenza A viruses. PLoS Pathog 9, e1003657.
27. Tumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E. & Basler, C. F. (2004). Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 101, 3166-3171.
28. Uyeki, T. M. & Cox, N. J. (2013). Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med 368, 1862-1864.
29. Wang, M. L., Skehel, J. J. & Wiley, D. C. (1986). Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol 57, 124-128.
30. WHO(2011). Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2010. Wkly Epidemiol Rec 86, 161-166.
31. Wiley, D. C., Wilson, I. A. & Skehel, J. J. (1981). Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378.
32. Wright, P. F., Neumann, G. & Kawaoka, Y. (2007). Orthomyxoviruses. In Fields Virology, 5th edn, pp. 1691-1740. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Wolters Kluwer/Lippincott Wlliams & Wilkins.
33. Xu, R., Ekiert, D. C., Krause, J. C., Hai, R., Crowe, J. E., Jr & Wilson, I. A. (2010). Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-360.
34. Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A. & other authors (2008). Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532-536.
35. Zhang, W., Qi, J., Shi, Y., Li, Q., Gao, F., Sun, Y., Lu, X., Lu, Q., Vavricka, C. J. & other authors (2010). Crystal structure of the swineorigin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell 1, 459-467.